Anaphylatoxin Complement 5a in Pfizer BNT162b2-Induced Immediate-Type Vaccine Hypersensitivity Reactions

Author:

Lim Xin Rong1ORCID,Chan Grace Yin Lai1,Tan Justina Wei Lynn1,Ng Carol Yee Leng1,Chua Choon Guan1,Tan Guat Bee2,Chan Stephrene Seok Wei2,Ong Kiat Hoe2,Tan Ying Zhi3,Tan Sarah Hui Zhen3,Teo Claire Min Li1,Lee Samuel Shang Ming1,Thong Bernard Yu Hor1,Leung Bernard Pui Lam13ORCID

Affiliation:

1. Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore 308433, Singapore

2. Department of Haematology, Tan Tock Seng Hospital, Singapore 308433, Singapore

3. Health and Social Sciences, Singapore Institute of Technology, Singapore 138683, Singapore

Abstract

The underlying immunological mechanisms of immediate-type hypersensitivity reactions (HSR) to COVID-19 vaccines are poorly understood. We investigate the mechanisms of immediate-type hypersensitivity reactions to the Pfizer BNT162b2 vaccine and the response of antibodies to the polyethylene glycol (PEG)ylated lipid nanoparticle after two doses of vaccination. Sixty-seven participants, median age 35 and 77.3% females who tolerated two doses of the BNT162b2 vaccine (non-reactors), were subjected to various blood-sampling time points. A separate group of vaccine reactors (10 anaphylaxis and 37 anonymised tryptase samples) were recruited for blood sampling. Immunoglobulin (Ig)G, IgM and IgE antibodies to the BNT162b2 vaccine, biomarkers associated with allergic reaction, including tryptase for anaphylaxis, complement 5a(C5a), intercellular adhesion molecule 1 (ICAM-1) for endothelial activation and Interleukin (IL)-4, IL-10, IL-33, tumour necrosis factor (TNF) and monocyte chemoattractant protein (MCP-1), were measured. Basophil activation test (BAT) was performed in BNT162b2-induced anaphylaxis patients by flow cytometry. The majority of patients with immediate-type BNT162b2 vaccine HSR demonstrated raised C5a and Th2-related cytokines but normal tryptase levels during the acute reaction, together with significantly higher levels of IgM antibodies to the BNT162b2 vaccine (IgM 67.2 (median) vs. 23.9 AU/mL, p < 0.001) and ICAM-1 when compared to non-reactor controls. No detectable IgE antibodies to the BNT162b2 vaccine were found in these patients. The basophil activation tests by flow cytometry to the Pfizer vaccine, 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol (DMG-PEG) and PEG-2000 were negative in four anaphylaxis patients. Acute hypersensitivity reactions post BNT162b2 vaccination suggest pseudo-allergic reactions via the activation of anaphylatoxins C5a and are independent of IgE-mechanisms. Vaccine reactors have significantly higher levels of anti-BNT162b2 IgM although its precise role remains unclear.

Funder

Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital

National Centre for Infectious Diseases, Singapore

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference36 articles.

1. (2022, August 20). World Health Organization [Internet]. Geneva: World Health Organization; c2022. Weekly Epidemiological Update on COVID-19-17 August 2022; [about 1 Screen]. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---17-august-2022.

2. (2022, August 20). World Health Organization [Internet]. Geneva: World Health Organization; c2022. COVID-19 in Singapore Situation Report 61; [about 1 Screen]. Available online: https://www.who.int/singapore/internal-publications-detail/covid-19-in-singapore-situation-report-61.

3. CDC COVID-19 Response Team, and Food and Drug Administration (2021). Allergic Reactions Including Anaphylaxis after Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine-United States, December 14–23, 2020. MMWR Morb. Mortal. Wkly. Rep., 70, 46–51.

4. Risk of anaphylaxis after vaccination in children and adults;McNeil;J. Allergy Clin. Immunol.,2016

5. (2022, August 20). Health Sciences Authority [Internet]. Singapore: Health Sciences Authority; c2020. Interim Authorisation of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) for Active Immunisation to Prevent COVID-19 Disease in Singapore; [about 1 Screen], Available online: https://www.hsa.gov.sg/announcements/dear-healthcare-professional-letter/interim-authorisation-of-pfizer-biontech-covid-19-vaccine-(bnt162b2)-for-active-immunisation-to-prevent-covid-19-disease-in-singapore.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3